Related Experiment Video
Updated: Jul 25, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Blood group A enhances SARS-CoV-2 infection
Shang-Chuen Wu1, Connie M Arthur1, Hau-Ming Jan1
1Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) preferentially infects blood group A cells. This occurs because the SARS-CoV-2 receptor-binding domain specifically binds to blood group A antigens.
Area of Science:
- Virology
- Immunology
- Glycobiology
Background:
- ABO(H) blood group antigens are recognized risk factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
- Mechanisms linking ABO(H) antigens to COVID-19 susceptibility are not fully understood.
- The SARS-CoV-2 receptor-binding domain (RBD) shares similarities with galectins, which are carbohydrate-binding proteins.
Purpose of the Study:
- To investigate the glycan-binding specificity of SARS-CoV-2 RBD.
- To compare SARS-CoV-2 RBD binding with that of galectins.
- To elucidate the role of ABO(H) blood group antigens in SARS-CoV-2 infection.
Main Methods:
- Utilized glycan array analysis to compare binding profiles of SARS-CoV-2 RBD and galectins.
- Assessed the infectivity of SARS-CoV-2 variants (including Delta and Omicron) on blood group A-expressing cells.
- Investigated the inhibitory effect of galectins on SARS-CoV-2 infection of blood group A cells.
Main Results:
- SARS-CoV-2 RBD, including Delta and Omicron variants, demonstrated specificity for blood group A.
- SARS-CoV-2 viruses showed a preferential ability to infect blood group A-expressing cells.
- A blood group-binding galectin inhibited SARS-CoV-2 infection enhancement in blood group A cells, while a non-binding galectin did not.
Conclusions:
- SARS-CoV-2 directly engages blood group A antigens.
- This binding provides a direct mechanistic link between ABO(H) blood group expression and SARS-CoV-2 infection susceptibility.
- The findings offer insights into host-pathogen interactions in COVID-19.
Abstract:
Among the risk factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ABO(H) blood group antigens are among the most recognized predictors of infection. However, the mechanisms by which ABO(H) antigens influence susceptibility to COVID-19 remain incompletely understood. The receptor-binding domain (RBD) of SARS-CoV-2, which facilitates host cell engagement, bears significant similarity to galectins, an ancient family of carbohydrate-binding proteins. Because ABO(H) blood group antigens are carbohydrates, we compared the glycan-binding specificity of SARS-CoV-2 RBD with that of galectins. Similar to the binding profile of several galectins, the RBDs of SARS-CoV-2, including Delta and Omicron variants, exhibited specificity for blood group A. Not only did each RBD recognize blood group A in a glycan array format, but each SARS-CoV-2 virus also displayed a preferential ability to infect blood group A-expressing cells. Preincubation of blood group A cells with a blood group-binding galectin specifically inhibited the blood group A enhancement of SARS-CoV-2 infection, whereas similar incubation with a galectin that does not recognize blood group antigens failed to impact SARS-CoV-2 infection. These results demonstrated that SARS-CoV-2 can engage blood group A, providing a direct link between ABO(H) blood group expression and SARS-CoV-2 infection.
More Related Videos
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Rh Blood Group
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...